Validation of an Automated Quantitative Digital Pathology Approach for Scoring TMEM: A Prognostic Biomarker for Metastasis
Open Access
- 31 March 2020
- Vol. 12 (4), 846
- https://doi.org/10.3390/cancers12040846
Abstract
Metastasis causes ~90% of breast cancer mortality. However, standard prognostic tests based mostly on proliferation genes do not measure metastatic potential. Tumor MicroEnvironment of Metastasis (TMEM), an immunohistochemical biomarker for doorways on blood vessels that support tumor cell dissemination is prognostic for metastatic outcome in breast cancer patients. Studies quantifying TMEM doorways have involved manual scoring by pathologists utilizing static digital microscopy: a labor-intensive process unsuitable for use in clinical practice. We report here a validation study evaluating a new quantitative digital pathology (QDP) tool (TMEM-DP) for identification and quantification of TMEM doorways that closely mimics pathologists’ workflow and reduces pathologists’ variability to levels suitable for use in a clinical setting. Blinded to outcome, QDP was applied to a nested case-control study consisting of 259 matched case-control pairs. Sixty subjects of these were manually scored by five pathologists, digitally recorded using whole slide imaging (WSI), and then used for algorithm development and optimization. Validation was performed on the remainder of the cohort. TMEM-DP shows excellent reproducibility and concordance and reduces pathologist time from ~60 min to ~5 min per case. Concordance between manual scoring and TMEM-DP was found to be >0.79. These results show that TMEM-DP is capable of accurately identifying and scoring TMEM doorways (also known as MetaSite score) equivalent to pathologists.Funding Information
- National Institutes of Health (CA100324, CA216248)
- Lipper Family Foundation (Integrated Imaging Program, Gruss-Lipper Biophotonics Center)
This publication has 34 references indexed in Scilit:
- Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancerBreast Cancer Research, 2012
- Virtual microscopy using whole-slide imaging as an enabler for teledermatopathology: A paired consultant validation studyJournal of Pathology Informatics, 2012
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast CancerJournal of Clinical Oncology, 2011
- Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous DisseminationClinical Cancer Research, 2009
- Improved learning efficiency and increased student collaboration through use of virtual microscopy in the teaching of human pathologyAnatomical Sciences Education, 2008
- Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary TumorsCancer Research, 2007
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary TumorsCancer Research, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerThe New England Journal of Medicine, 2002
- Study of Interlaboratory Reliability and Reproducibility of Estrogen and Progesterone Receptor Assays in EuropeAmerican Journal of Clinical Pathology, 2001